News + Events

Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)

Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial Not Allowed)

Notice of Special Interest (NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE Project

ARPA-H Launches New Funding Opportunity

CATALYST (Computational ADME-Tox and Physiology Analysis for Safer Therapeutics) program intends to create human physiology-based computer models to accurately predict safety and efficacy profiles for Investigational New Drug (IND) candidates.

How to apply: Visit the CATALYST program page for details on how to register for the program’s upcoming hybrid Proposers’ Day in Cincinnati on October 29, 2024, and how to submit a proposal. You can also view the draft CATALYST innovative Solutions Opening on SAM.gov.

BII & Science | Prize for Innovation

To encourage more scientists to translate their research, BioInnovation Institute (BII) and Science collaborate to host an annual award. Through the BioInnovation Institute & Science Prize for Innovation, the editors of Science seek to recognize bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship.

Our three winners will have their essays published in Science and will be invited into BII’s entrepreneurial ecosystem. In addition, the Grand Prize winner will receive a prize of USD 25,000 and each runner-up will receive USD 10,000 at a grand award ceremony in Copenhagen, Denmark.

DRIVe EZ-BAA Funding Opportunities

This funding opportunity partners with companies and teams offering solutions to a broad range of national health security threats. DRIVe partnering approaches vary depending on the project. DRIVe has two funding opportunities under our EZ-BAA for awards under $750K and + Phase awards up to $20M.

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Osteology Foundation Peter and Annemarie Geistlich-Stucki Grant

The Osteology Foundation aims to support clinical research in the field of oral tissue regeneration, to bridge the gap between scientific progress and clinical practice for the benefit of the patient.

The purpose of the Geistlich-Stucki Foundation is to promote medical research and teaching on a nonprofit basis. The focus of their activities is on tissue regeneration with biological materials, especially in oral and maxillofacial surgery, and in the field of cancer treatment.

The two foundations have now joint forces and developed a joint grant programme to address sound clinical research questions in the field of oral and maxillofacial tissue regeneration.

NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)

NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)

NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Basic Experimental Studies Involving Humans Required)

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Required)

NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Basic Experimental Studies Involving Humans Required)

HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective PainTreatment (R01 Clinical Trial Not Allowed)

AADOCR/IADR Awards and Fellowship deadlines are approaching soon!

Explore our vast portfolio of awards, grants, fellowships, and competitions for all career stages using the keyword search or the filters to the side to find awards based on type or scientific area.

• AADOCR Anne D. Haffajee Fellowship
• AADOCR Delta Dental Institute Oral Health Equity Award
• AADOCR Irwin D. Mandel Distinguished Mentoring Award
• AADOCR Procter & Gamble Underrepresented Faculty Research Fellowship
• AADOCR William Butler Fellowship
• AADOCR William B. Clark Fellowship
• IADR Distinguished Service Award
• IADR Dianne Rekow Mentoring in Science Award
• IADR E.W. Borrow Memorial Award
• IADR Toshio Nakao Fellowship
• IADR/AADOCR William J Gies Award

For a full list, see: https://www.iadr.org/awards

We anticipate publishing the PHS 2024-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications in late spring of 2024 with an expected first application due date in September 2024.

These notices of funding opportunities (NOFOs) will be a reissuance of the following omnibus solicitations:

• PA-23-230: PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed).
• PA-23-231: PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required).
•  PA-23-232: PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed).
• PA-23-233: PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required).

Please refer to the notice (NOT-OD-24-087) for more information.

The Alan T. Waterman Award recognizes an outstanding early career researcher in any field of science or engineering supported by the U.S. National Science Foundation. The annual award is the nation’s highest honor for early-career scientists and engineers. In addition to a medal, the awardee receives a grant of $1,000,000 over a five-year period for scientific research or advanced study in the science and engineering disciplines supported by the National Science Foundation at the institution of their choice.

Administrative Supplements to Promote Diversity in Small Businesses – SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

The Small Business Transition Grant for New Entrepreneurs Notices of Funding Opportunities (NOFOs) aim to support career development and the conduct of research and development under a new entrepreneur’s direction.

Optimal Program Directors/Principal Investigators (PDs/PIs) for this award are early-career scientists and professionals with research, technology development, and/or healthcare delivery skills and experience, but limited entrepreneurial and independent (non-mentored) research leadership experience.

NIH is committed to diversifying the entrepreneurial workforce and encourages applications from individuals who offer unique and/or underrepresented perspectives that enrich the biomedical innovation pipeline.

• Award Types: Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR), Phase I and Fast-Track
• Eligibility: PDs/PIs must have never been an independent PD/PI on a major research grant and must be a U.S. Citizen or Lawful Permanent Resident
• Mentor(s): Applicants must identify mentor(s) to:
  • Provide technical and commercial guidance to advance the proposed research project
  • Support preparing and executing a career development plan to successfully navigate the entrepreneurial process, develop and commercialize products, or operate a small business
• Due Dates: September 5, January 5, and April 5 (or the next business day, if falling on a weekend or Federal holiday)

The Small Business Transition Grant for New Entrepreneurs Notices of Funding Opportunities (NOFOs) aim to support career development and the conduct of research and development under a new entrepreneur’s direction.  Optimal Program Directors/Principal Investigators (PDs/PIs) for this award are early-career scientists and professionals with research, technology development, and/or healthcare delivery skills and experience, but limited entrepreneurial and independent (non-mentored) research leadership experience.

Due Dates: September 5, January 5, and April 5

The PHS 2024-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications have been released. The first application due date is Thursday, September 5, 2024, so start preparing your application today.

There are four Omnibus Solicitations:

• PA-24-245: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed).
• PA-24-246: PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required).
• PA-24-247: PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed).
• PA-24-248: PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required).

Notice of Information: Anticipated Publication of the PHS 2024-2 Omnibus Solicitations of the NIH, CDC and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications

The National Osteology Group USA is inviting residents and young dentists to participate in its first Case Competition.

Two competition categories are open for submission:

Soft tissue or periodontal regeneration around teeth
Soft or hard tissue regeneration around implants

Three finalists in each category will be invited to present their case during the AAP Annual Meeting in San Diego. Among these, two winners will be selected and awarded.

Deadline for submission is 15 July 2024.

Osteology Foundation Applied Research Grant

The Osteology Foundation aims to support scientific research and education projects in the field of oral tissue regeneration. To actively promote translational and clinical research, the Osteology Foundation awards grants to selected researchers yearly.

NIDCR Guidance on Applications for Investigator – Initiated Clinical Trials

CareQuest Innovation‘s accelerator program, SMILE Health, call for applications is now open until May 8.  Please see details and application here: https://carequestinnovation.com/smile-health/, and direct questions to smilehealth@carequestinnovation.com.

The Orthopaedic Research Society (ORS) and the Orland Bethel Family Musculoskeletal Research Center (BMRC) have joined together to offer a fellowship to early career scientists. The ORS/BMRC Fellowship prioritizes support of early career scientists to produce breakthrough treatments for musculoskeletal ailments. The program will support the generation of critical preliminary data for larger grant applications, leading to breakthrough treatments for musculoskeletal diseases. Two levels of fellowship support are currently available to support translational basic science and clinical musculoskeletal research: $20,000 awards for postdoctoral scholars or medical residents, and $30,000 awards for junior faculty members.

NIH SBIR & STTR Grant Funding Opportunities

Standard Application Due Dates: September 5, January 5, and April 5.

The University of Michigan School of Dentistry (UMSD) and Biosciences Initiative (BSI) invite nominations and applications for a tenure track faculty position in the areas of biomaterials and regenerative medicine, at the Assistant or Associate Professor level. Passionate scientists who use ground-breaking approaches to advance the field of regenerative medicine, increasing translatability of new therapies, and who are committed to joining a vibrant research community are sought.

The Pew Scholars Program in the Biomedical Sciences is designed to support young investigators of outstanding promise in science relevant to the advancement of human health. The program supports the independent research of assistant professors in the first four years of their appointment, as they establish their laboratories.

As a nonprofit organization, MTF Biologics reinvests to positively affect lives across the globe by offering Allograft Innovation Grants for funding translational and clinical research to advance Allograft Tissue Transplantation and support our mission to Save and Heal Lives. Funding is available for both Allograft Translational Research and Allograft Clinical Research projects. Awarded grants are aimed at advancing allograft tissue transplantation science and patient care. Submitted research projects must utilize allografts or allograft-derived materials, and must have a strong clinical translation component.

Clinical areas of interest include: Orthopedics, Spine, Sports Medicine, Plastic & Reconstructive Surgery, Aesthetics, Surgical Soft Tissue Repair and Reconstruction, Wound Care, or other areas which utilize allograft transplant technologies.

Proposed studies should focus on innovative translational and clinical research in the fields of tissue allograft transplantation and science, novel uses of allografts, combination with other biomaterials to enhance properties, and transformative regenerative medicine technologies relying on allograft tissues and matrices.

Calling all early-career independent creative researchers and engineering entrepreneurs. AIChE invites you to apply for The Langer Prize for Innovation and Entrepreneurial excellence. Learn more about this unrestricted grant (up to $100K) and how to apply.

Students enrolled in an accredited DDS/DMD, combined DDS/PhD program or hygiene program in a dental (health-associated) institution within the USA are invited to submit research proposals for the AADOCR Student Research Fellowships. These Fellowships, supported by several major industrial companies, as well as by AADOCR and IADR Group Chapters, Sections, and members, are sponsored and administered by the AADOCR and have been created to encourage dental students living in the United States to consider careers in oral health research. Proposals are sought in basic and clinical research related to oral health.

NIH SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development now open

The Notice of Funding Opportunity aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R&D) not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services. Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the Small Business Concern (SBC) is expected to maintain oversight and management of the R&D throughout the award.

https://grants.nih.gov/grants/guide/pa-files/par-23-219.html
(Clinical Trial Not Allowed)

https://grants.nih.gov/grants/guide/pa-files/par-23-220.html
(Clinical Trial Required)

The NIH Small Business Program is accepting applications for SBIR & STTR funding. Learn more about these open opportunities.

Learn how to apply and what to do if you encounter systems issues.

Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Partnership for Innovation Research Projects (U01 Clinical Trial Not Allowed)

John Templeton Foundation: The Life Sciences portfolio supports research and engagement projects on such questions. We are particularly interested in applications that seek novel and fundamental insights into the meaning and significance of life processes, by which we can better understand humanity’s place within nature. We support experimental and theoretical work on a broad range of areas and topics, including origins of life, complexity, emergence, evolution, human development, and ecological health and interventions.

IADR Osteology Foundation New Investigator Award in Oral Tissue Regeneration

The Osteology Foundation promotes research, education and collaboration between universities and industry in the field of oral and maxillofacial tissue regeneration. The Osteology Foundation aims to bridge the gap between scientific progress and clinical practice, as well as between academic and industrial researchers in the field of oral tissue regeneration.

Funding research into all aspects of oral tissue regeneration is a core task of the Osteology Foundation.

Abstract submission for our Joint Large Clinical Grant programme is open now. From 1 September until 15 November 2023 abstracts by well-established researchers/research-groups with a clinical focus on oral maxillofacial tissue regeneration topics are being accepted.

The FY24 SBIR contract solicitation has been released.

The solicitation lists specific need areas (referred to as Contract Topics). To submit a contract proposal, your small business must respond to one of these topics.

View the solicitation (PHS-2024-1) and learn about the differences between grants and contracts.

Proposals are due by Tuesday, Nov. 14, 2023, at 05:00 p.m. EDT.

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

SENS Research Foundation regularly funds external research with potential to accelerate the development of rejuvenation biotechnology. Applicants for financial support will be expected to clearly indicate the specific SENS target(s) addressed and explain how their proposed research would further progress toward therapies that remove, repair, replace, or render harmless that target. All proposals are reviewed and selected by our Research Development Committee (RDC), and its decisions are ratified by our Board of Directors.  The RDC convenes quarterly. Submission due dates are as follows:

• First Quarter review: by February 1st
• Second Quarter review: by May 1st
• Third Quarter review: by August 1st
• Fourth Quarter review: by November 1st

National Science Foundation (NSF)

• FY23 Solicitations:
  • NSF Combined Phase I SBIR/STTR Solicitation: NSF23-515
  • NSF Combined Phase II SBIR/STTR Solicitation: NSF23-516
• Submission window for Phase I/Phase II proposals in 2023:
  • November 22, 2022 — March 1, 2023
  • March 2, 2023 — July 5, 2023
  • July 6, 2023 — November 1, 2023

Behind every life-changing solution is an entrepreneurial scientist–a creative mind who developed an idea in the lab and dared to carry it out in the world.

To encourage more scientists to translate their research, BioInnovation Institute (BII) & Science host an annual award.

Up to three winners will have their essays published in Science magazine and will be invited into BII’s entrepreneurial ecosystem. In addition, the Grand Prize winner will receive a prize of USD 25,000 and each finalist will receive USD 10,000 at a grand award celebration in Copenhagen, Denmark.

The call for applications has just opened.
Apply before November 1, 2023

The Hertz Fellowship is awarded annually to the nation’s most promising graduate students in science and technology. Using a rigorous, merit-based process, we identify innovators with the greatest potential to create transformative solutions to the world’s most urgent challenges.

RFA-AG-24-042 and RFA-AG-24-043: The REDI Entrepreneurial Small Business Transition Awards foster career development among scientists with an interest in entrepreneurial training and mentorship while supporting the development of their small business and facilitating their transition from academia to industry.

Share your innovative research and you can be awarded USD $30,000 and get your work published in Science.

The Michelson Philanthropies & Science Prize for Immunology is awarded annually to honor bold and transformative research in human immunology with trans-disease applications.

This honor was created to encourage, support, and reward young investigators across disciplines who demonstrate expertise with the potential for lasting impact on vaccine and immunotherapy discovery.

This international prize is an investment in the future—you and your research. The prize is USD $30K, and two finalists receive USD $10K each.

To enter, submit an application describing your research and why you think it’s a game changer in the field of immunology. The deadline to apply is 1 October 2023.

Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) | Application Due: April 5, 2023 & September 5, 2023

• HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) | Application Due: April 4, 2023 & September 4, 2023
• HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) | Application Due: April 4, 2023 & September 4, 2023

Through the Disability Inclusion and Justice in Oral Health Request for Proposals (RFP), CareQuest Institute will fund projects and partner with organizations that are working to address systemic barriers to oral health — including access to oral health — for people with disabilities. CareQuest Institute will fund 10 projects for up to $125,000 each.

Notice of Special Interest (NOSI): Translating Biomaterials-Based Technologies to Commercially Viable Products

Through the Community and Care Transformation Initiative, CareQuest Institute is seeking to fund projects and partners that carry forward care transformation concepts and ensure authentic and deep community engagement. CareQuest will fund 10 projects for up to $125,000 each

Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)

The AO is a medically-guided, not-for-profit organization, a global network of surgeons, and the premier education, innovation, and research organization for the surgical treatment of trauma and musculoskeletal disorders

Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)

• SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) | Application Due: April 5, 2023
• SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) | Application Due: April 5, 2023
• SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) | Application Due: April 5, 2023

Omnibus Solicitations | Application Due: April 5, 2023

MTF Biologics Request for Proposals – 2023 Clinical Research Grant LoI due: 03/15/2023

MTF Biologics Request for Proposals – 2023 Extramural Research Grant LoI due: 03/15/2023

MTF Biologics Request for Proposals: 2023 Dr. William F. Enneking Career Development Grant LoI due: 03/15/2023

Planning for the TMD Collaborative for Improving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed) | Application Due: March 14, 2023

Army SBIR CATALYST Program | Application Due: February 20, 2023

Osteo Science Foundation: OMS Fellowship. Application Due January 31, 2023

IADR Osteology Foundation Grant. Application due January 30, 2023.

AHEAD (Advancing Head & Neck Cancer Early Detection Research) (U01 Clinical Trial Not Allowed)

Calling mid-career NIDCR-supported scientists! Do you have a trailblazing research idea with the potential to improve dental, oral, or craniofacial health? NIDCR invites you to apply for a Sustaining Outstanding Achievement in Research (SOAR) award. The awards aim to provide longer term support for mid-career investigators with outstanding research records to pursue high-risk, high-reward research.

Eligibility: NIDCR-funded mid-career investigators
Award amount: Up to $650,000 per year
Award length: Up to eight years
Application due dates: January 26, 2024, for new applications. February 13, 2024, for AIDS-related submissions.

Orthopaedic Research and Education Foundation (OREF) Osteoarthritis Research Grant

Orthopaedic Research and Education Foundation/Musculoskeletal Transplant Foundation Research Grant Request for Applications

Orthopaedic Research and Education Foundation (OREF) Multimodal Musculoskeletal Perioperative Pain Management Grant in Collaboration With the American Association of Nurse Anesthetists (AANA) Foundation Request for Applications

The American Association of Cancer Research has opened up a new funding opportunity for researchers. The Bosarge Family Foundation-Waun Ki Hong Scholar Award for Regenerative Cancer Medicine is a $120,000 grant over two years to support postdoctoral or clinical research fellows to conduct highly novel and provocative research in the field of regenerative cancer medicine and to establish a successful career path in this field. To learn more about this opportunity and to apply to go the award website.

The National Institute of Dental and Craniofacial Research (NIDCR) has published a new Funding Opportunity Announcement: RFA-DE-23-012: Practice-Based Research Integrating Multidisciplinary Experiences in Dental Schools (PRIMED) (U01 Clinical Trial Not Allowed)

Osteology Foundation: Advanced Researcher Grants. Application due December 1st.

Osteology Foundation: Young Researcher Grants. Application due December 1st.

Osteology Foundation: Osteology Research Scholarships. Application due December 1, 2022.

Peter Geistlich Research Award. Application Due December 1, 2022

Philip J. Boyne Research Award. Application Due December 1, 2022

Osteo Science Foundation: OMS Resident Research Awards. Application Due December 1, 2022

Harnessing Technologies to Support Oral Health Promotion and Management Outside the Dental Setting (UG3/UH3 Clinical Trial Required)

NIH Dental Public Health Research Fellowship | Application Due: November 21, 2022

Peter and Annemarie Geistlich-Stucki Grant by Osteology Foundation. Application due November 15, 2022.

Notice of Intent to Publish a Funding Opportunity Announcement for Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (R61/R33 Clinical Trial Not Allowed)

Notice of Intent to Publish a Funding Opportunity Announcement for Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (Fast-Track – R42 Clinical Trial Not Allowed)

Notice of Intent to Publish a Funding Opportunity Announcement for Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials (Fast-Track – R44 Clinical Trial Not Allowed)

Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science Program | Application Due: November 10, 2022

Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Research Education Program (UE5 Clinical Trial Not Allowed)

Notice of Special Interest (NOSI): Administrative Supplement for Research Efforts that Illuminate Fundamental Processes Underlying Behavior Change, Maintenance, and Adherence (Admin Supp Clinical Trial Optional)

Applicants will submit a 1000-word essay that is judged by an independent editorial team, organized by the journal Science. If selected as a winner, you will have your essay published by Science, win up to USD 30,000 and be invited to Sweden to receive your award, present your research and meet with leading scientists in your field. Applications are due July 15, 2022.

The RegenMed Development Organization (ReMDO) is excited to announce a grant opportunity intended to create a continued impact on the rate of clinical translation for regenerative medicine therapies and the commercialization of regenerative medicine products within the global market. Application due July 1, 2022.

Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)

National Science Foundation Biological Sciences: Industry-University Cooperative Research Centers Program open for applications, due June 8, 2022

Notice of Special Interest (NOSI): Achieving Tissue Robustness Through Harnessing Immune System Plasticity

National Science Foundation Biological Sciences: New Convergence Accelerator Funding opportunity. Two different submission pathways, track focuses include: enhancing opportunities for persons with disabilities, sustainable materials for global challenges, and food & nutrition security. Letter of intent due by May 31, 2022

The new Osteology Advanced Research Traineeship (ART) funding programme is now online! The ART programme aims to strengthen the link between research and education through a short-term research-based training and learning approach. Submission deadline is 15 May 2022!

The new Osteology Advanced Research Traineeship (ART) funding programme is now online! The ART programme aims to strengthen the link between research and education through a short-term research-based training and learning approach. Submission deadline is 15 May 2022!

Osteology Foundation: Osteology Advanced Research Traineeships. Application due May 15, 2023.

Notice of Special Interest (NOSI): Administrative Supplements for NIDCR Grants to Support Pain-Focused High Priority Research Areas

Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)

HEAL Initiative: Restoring Joint Health and Function to Reduce Pain Consortium (RE-JOIN) (UC2 Clinical Trial Not Allowed)

HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed)

HEAL Initiative: Advancing Health Equity in Pain and Comorbidities (R61/R33 Clinical Trial Required)

Behind every life-changing solution is an entrepreneurial scientist. A creative mind who proved an idea in the lab and dared to carry it out in the world. To encourage more scientists to translate their research, BioInnovation Institute (BII) & Science present a new annual award. The three winners will have their essays published in Science magazine and will be invited into BII’s entrepreneurial ecosystem. In addition, the Grand Prize winner will receive a prize of USD 25,000 and each runner-up will receive USD 10,000 at a grand award show celebration in Copenhagen, Denmark.

The Biointerfaces Institute is seeking applications for an inaugural cohort of BI Innovation Fellows. The Innovation Fellowship is a full-time position for up to two years at a competitive $60,000 salary with full benefits. The program offers a unique opportunity for Fellows to be embedded within the BI research and translational ecosystem to explore research commercialization